Biopharmaceutical CMO & CRO Market Worth $54.1 Billion By 2030
Biopharmaceutical CMO and CRO Industry Overview The global biopharmaceutical CMO and CRO market size was valued at USD 29.4 billion in 2021 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.6% over the forecast period. There was unprecedented growth in 2020 due to the COVID-19 pandemic. The rising investments in the biopharmaceutical industry by the prominent participants to enhance their productivity and efficiency have driven the bio manufacturers to increase their focus on outsourcing activities. Currently, biopharma companies have begun outsourcing the resource and capital-intensive steps and, in a few cases, the entire chain of biomanufacturing, thereby boosting the demand for contract-based services. Gather more insights about the market drivers, restrains and growth of the Global Biopharmaceutical CMO And CRO Market The coronavirus pandemic has resulted in disruptions in the supply chain of the overall pharmaceutical industry. However, t...